Quantum Biopharma (QNTM) Change in Account Payables (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Change in Account Payables data on file, last reported at -$3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 1738.04% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$1.9 million (down 137.07% YoY), and the FY2025 full-year result was $1.2 million, down 72.4% from the prior year.
• Change in Account Payables retreated to -$3.3 million in Q1 2026, from -$214343.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.1 million in Q4 2024 to a low of -$3.3 million in Q1 2026.
• A 5-year average of $208048.6 and a median of $438640.0 in 2022 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables jumped 443.46% in 2024 and tumbled 1738.04% in 2026, its largest moves.
• Tracing QNTM's Change in Account Payables over 5 years: stood at $723769.0 in 2022, then fell by 20.54% to $575080.0 in 2023, then jumped by 443.46% to $3.1 million in 2024, then tumbled by 106.86% to -$214343.0 in 2025, then slumped by 1421.9% to -$3.3 million in 2026.
• Business Quant data shows QNTM's Change in Account Payables at -$3.3 million in Q1 2026, -$214343.0 in Q4 2025, and $1.4 million in Q3 2025.